NHS Evidence, launched in April 2009, allows everyone in health and social care to access the latest clinical and non-clinical evidence and best practice, to help them make informed decisions. This article outlines how nurses can make best use of the service and explains its features. From October, one of these is helping users to identify the best evidence by awarding an accreditation mark to the most reliable sources of guidance.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Environmental impact of commonly used anaesthetic agents: systematic literature review with narrative synthesis.
BJA Open
March 2025
Department of Anaesthesia, The William Harvey Hospital, Ashford, UK.
Background: Increasing awareness of the potential environmental impact of volatile anaesthetic agents has stimulated increased use of total i.v. anaesthesia.
View Article and Find Full Text PDFHigher hospital volume reduces early failure rates in single-stage revision TKR for infection: An analysis of the United Kingdom National Joint Registry and National Administrative Databases.
Knee Surg Sports Traumatol Arthrosc
January 2025
Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Purpose: Revision knee replacement (RevKR) for infection is rare but increasing. It is hypothesised that higher hospital volume reduces adverse outcomes. The aim was to estimate the association of surgical unit volume with outcomes following first, single-stage RevKR for infection.
View Article and Find Full Text PDFThe current clinical approach to feeding and eating disorders aimed to increase personalization of management.
World Psychiatry
February 2025
School of Health in Social Science, University of Edinburgh, Edinburgh, UK.
Feeding and eating disorders (FEDs) are a heterogeneous grouping of disorders at the mind-body interface, with typical onset from childhood into emerging adulthood. They occur along a spectrum of disordered eating and compensatory weight management behaviors, and from low to high body weight. Psychiatric comorbidities are the norm.
View Article and Find Full Text PDFSmall molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast.
Reumatismo
January 2025
Rheumatology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo.
Objective: Idiopathic inflammatory myopathies (IIM) are rare autoimmune diseases that primarily affect striated muscles; skin, joints, and lungs may be involved with different degrees of severity. Traditional treatment relies on high-dose glucocorticoids and conventional synthetic disease-modifying antirheumatic drugs.
Methods: A growing amount of evidence is demonstrating the potential role of novel treatments in the management of IIM.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!